Chronix Biomedical - Ownership and Business Overview

Medical ProductsCompany

Chronix Biomedical Ownership

Who owns Chronix Biomedical?

Chronix Biomedical is owned by OncoCyte. It was acquired on October 1, 2020.

Chronix Biomedical Business Overview

Where is Chronix Biomedical headquartered?

Chronix Biomedical is headquartered in San Jose, California.

What sector is Chronix Biomedical in?

Chronix Biomedical is a medical products company.

When was Chronix Biomedical founded?

Chronix Biomedical was founded in 1997.

Medical Products M&A Summary in 2020

Out of 60 sectors in the Mergr database, medical products ranked 12 in number of deals in 2020. The largest medical products acquisition in 2020 was Livongo Health - which was acquired by Teladoc Health for $18.5B.

Join Mergr to view all 217 acquisitions of medical products companies in 2020, including 32 acquisitions by private equity firms, and 185 by strategics.

Chronix Biomedical

Chronix Biomedical, Inc.

5941 Optical Court Suite 201,
San Jose, California 95138
United States,
(408) 960-2306
www.chronixbiomedical.com

Chronix Biomedical is a molecular diagnostics company developing blood tests for use in cancer treatment and organ transplantation. Chronix’s TheraSure CNI Monitor for cancer uses proprietary algorithms to derive a copy number instability (CNI) score from the sequencing of circulating cell-free tumor DNA (cfDNA), which can be used in the prognosis, diagnosis, and monitoring of therapeutic response to cancer. Chronix TheraSure™ Transplant Monitor quantifies the amount of graft-derived cell-free DNA in organ recipients to detect early rejection of organ transplants and better assess the transplant health. Chronix Biomedical was founded in 1997 and is based in San Jose, California.


 Subscribe to unlock this and 208,718
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.